These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 222813)

  • 1. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B; Ahern D
    J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
    Sharif NA; Crider JY; Xu SX; Williams GW
    J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding site for [3H]prostacyclin on platelets.
    Siegl AM; Smith JB; Silver MJ; Nicolaou KC; Ahern D
    J Clin Invest; 1979 Feb; 63(2):215-20. PubMed ID: 372237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
    Eggerman TL; Andersen NH; Robertson RP
    J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors.
    Oliva D; Nicosia S
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939
    [No Abstract]   [Full Text] [Related]  

  • 15. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes.
    Ashby B
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):291-300. PubMed ID: 2432105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
    Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
    Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thromboxane antagonists on prostaglandin regulation of platelet adenylate cyclase.
    Ashby B
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):241-50. PubMed ID: 2483174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
    Liang X; Wu L; Hand T; Andreasson K
    J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia.
    Wong P; Fujioka S; Yoshida S
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):147-54. PubMed ID: 3890456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.